Fermenta Biotech informs about outcome of board meeting

11 Nov 2022 Evaluate
Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on November 11, 2022 has approved the unaudited financial results for the quarter and half year ended September 30, 2022 (Standalone and Consolidated) as enclosed. It has enclosed the Limited Review Report dated November 11, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, SRBC & Co. LLP. The Board meeting commenced at 11.45 am and concluded at 02.55 pm.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

326.50 0.50 (0.15%)
22-Jan-2026 10:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1643.00
Dr. Reddys Lab 1217.50
Cipla 1380.50
Zydus Lifesciences 885.55
Lupin 2185.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×